Investors - Press Releases
Scientific Study Shows Correlation of Elevated Medication Risk Score with Death
The study, conducted by the
The appropriate use of medications is critical to avoid harm. The study establishes TRHC's MedWise Risk Score™ as the new, innovative standard for measuring risk that medication regimens pose.
"This study provides evidence that the medication risk score can be an effective predictor of mortality risk due to adverse drug events (ADEs)," said TRHC Chair and CEO
The study used electronic health record (EHR) data from more than 427,000 patients from multiple
To better understand if the increase in the MedWise Risk Score extends to increased mortality risk, researchers compared them with incidents of electronic health record (EHR) recorded death. After adjusting for common multi-morbidities and other conditions, the study showed that patients with EHR-recorded deaths had significantly higher MRS than others.
In addition, it was found that the risk varies by age group and by MRS category where the highest risk was seen among patients in the 30-49 year-age group that had an MRS of ≥20.
"This is a unique risk stratification model using drugs, not disease, to identify patients at increased risk of adverse drug effects, including death," said
"The Tabula Rasa medication algorithms are highly correlated with death and offer a remarkable opportunity to advance mediation safety. This study showed that they can be effectively used with electronic health record data. As they spread in clinical care ongoing evaluation of the impact of these advanced algorithms on clinical outcomes will be exciting next steps," said
View original content to download multimedia:http://www.prnewswire.com/news-releases/scientific-study-shows-correlation-of-elevated-medication-risk-score-with-death-301263034.html
TRHC Media Contact: Anthony Mirenda, firstname.lastname@example.org, 908-380-2143; or TRHC Investor Contact: Frank Sparacino, email@example.com